COVID-19

Showing 15 posts of 602 posts found.

Pfizer and Moderna test COVID-19 vaccines against new strain

December 22, 2020
Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine

Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …

credit_-_daniel_leal-olivas-afp

EU gives green light to Pfizer-BioNTech COVID-19 vaccine

December 22, 2020
Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine

The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …

fda2outsideweb

Moderna’s COVID-19 vaccine receives emergency approval from FDA

December 21, 2020
Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine

Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …

top10

Top Ten most popular articles on Pharmafile.com this week

December 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, antibody

The top news stories of the past week continue to centre around the COVID-19 pandemic; a new variant of the …

ipos0_l

Regeneron announces initial clinical data for COVID-19 antibody cocktail

December 18, 2020
Medical Communications COVID-19, Regeneron, antibody

Regeneron Pharmaceuticals has announced that initial clinical data published in the New England Journal of Medicine shows that its antibody …

nasal_spray

Ena Respiratory’s nasal spray reduces COVID-19 replication by 96%

December 18, 2020
Medical Communications COVID-19, Nasal Spray

Australian biotech Ena Respiratory has revealed that its self-administered nasal spray INNA-051, when taken once or twice weekly, reduced viral …

reuters_dado_ruvic

Novavax secures deal with New Zealand for 10.7m doses of COVID-19 vaccine

December 17, 2020
Sales and Marketing COVID-19, Novavax, Vaccine

Novavax has announced an Advance Purchase Agreement with New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, the …

FDA says Pfizer vaccine vials contain extra doses, boosting US supply

December 17, 2020
Sales and Marketing COVID-19, FDA, Pfizer, Vaccine

The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …

Quarter of the world may not access COVID-19 vaccine until 2022

December 16, 2020
Research and Development COVID-19, Vaccine

Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …

abbvie_0

AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020
Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …

3500

UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …

reuters_-_tatyana_makeyeva_1

Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …

1920px-city_of_london_skyline_from_london_city_hall_-_sept_2015_-_crop

New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …

fdaoutsideweb

FDA issues emergency use authorisation for Pfizer-BioNTech vaccine

December 14, 2020
Sales and Marketing COVID-19, FDA, US, Vaccine

The US Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in those aged 16 and …

shutterstock_95714119

Novartis and Incyte’s ruxolitinib fails to show benefit in COVID-19 at Phase 3

December 14, 2020
Research and Development, Sales and Marketing COVID-19, Incyte, Novartis

Novartis has unveiled that its JAK 1/2 tyrosine kinase inhibitor ruxolitinib fell short of its main efficacy goal in the …

The Gateway to Local Adoption Series

Latest content